ILMN
ILMN
NASDAQ · Life Sciences Tools & Services

Illumina Inc

$164.93
+3.55 (+2.20%)
Analyst Consensus
Buy
28
Analysts
High
Coverage
Buy 17 61%
Hold 8 29%
Sell 3 11%
Price Target
Analyst Price Target +2.7% upside
Low Target $114.37
Average Target $169.36
High Target $229.23
Current Price $164.93
Current
$164.93
Target
$169.36
$114.37 $169.36 avg $229.23
Scenario Analysis
Bear Case
$114.37
-30.7%
Low target
Base Case
$169.36
+2.7%
Avg target
Bull Case
$229.23
+39.0%
High target
Risk/Reward
1.3x
Balanced
Price in Context
52-Week High
$177.22
-6.9% from high
52-Week Low
$88.00
+87.4% from low
50-Day SMA
$136.22
+21.1% vs SMA
200-Day SMA
$108.49
+52.0% vs SMA
RSI (14)
17.5
Oversold
Target vs 52W High
$169.36
-4.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -21.3%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -11.7%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -48.9%
WAT
Waters Corp
Buy 28 57% $189.60 -46.9%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.6%
ILMN
Illumina Inc
Buy 28 61% $169.36 +2.7%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -59.5%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -85.3%